Tag: aTyr Pharma Inc.

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to aTyr Pharma Inc.

-$0.80 EPS Expected for aTyr Pharma, Inc. (NASDAQ:LIFE) This Quarter

Added to Collection on: 2021-01-11 16:36:22

Tags for this article:

Financial ratios
Companies
ATyr Pharma
Finance
Fundamental analysis
ANGI Homeservices
Price?earnings ratio
Shire
Earnings per share
Economy
aTyr Pharma Inc.

Click the tags to see associated articles and topics

View Article Details
aTyr Pharma (NASDAQ:LIFE) Downgraded to "Hold" at Zacks Investment Research

Added to Collection on: 2021-01-12 20:37:30

Tags for this article:

ATyr Pharma
BlackRock
Economy of New York City
Companies
Economy of the United States
United States
aTyr Pharma Inc.

Click the tags to see associated articles and topics

View Article Details
Other news to note for Feb. 11, 2021

Added to Collection on: 2021-02-11 23:48:45

Tags for this article:

Medical specialties
Medicine
Life Sciences
Immunology
Protalix BioTherapeutics
ATyr Pharma
Novartis
Alanine—tRNA ligase
Gaucher's disease
Aminoacyl tRNA synthetase
Monoclonal antibody
Beta-glucosidase
aTyr Pharma Inc.
United Kingdom
China

Click the tags to see associated articles and topics

View Article Details
aTyr Pharma, Inc. (NASDAQ:LIFE) Expected to Announce Earnings of -$0.80 Per Share

Added to Collection on: 2021-03-13 10:18:45

Tags for this article:

Finance
Money
Economy
Financial ratios
ATyr Pharma
Valuation
Corporate finance
Fundamental analysis
Hedge fund
ANGI Homeservices
Securities research
Price?earnings ratio
aTyr Pharma Inc.

Click the tags to see associated articles and topics

View Article Details
aTyr Pharma and its Hong Kong Subsidiary, Pangu BioPharma, Achieve Milestones for First Year ...

Added to Collection on: 2021-05-12 12:00:00

Tags for this article:

ATyr Pharma
Hong Kong
Immunology
Neuropilin 2
Hong Kong University of Science and Technology
Antibody
New Territories
Zhang Mingjie
Biology
aTyr Pharma Inc.
HKUST
Pangu BioPharma Limited

Click the tags to see associated articles and topics

View Article Details
Other news to note for May 12, 2021

Added to Collection on: 2021-05-12 22:41:15

Tags for this article:

Life Sciences
Medicine
Health sciences
Medical research
Inovio Pharmaceuticals
Monoclonal antibody
Biogen
Sanofi
Nanobiotix
COVID-19 vaccine
GenScript Biotech
Pangu Biopharma Ltd.
aTyr Pharma Inc.
Cambridge

Click the tags to see associated articles and topics

View Article Details
aTyr Pharma Presents Preclinical Research Highlighting Mechanistic Insights into Tumor Inhibitory ...

Added to Collection on: 2021-05-19 12:00:00

Tags for this article:

Branches of biology
Cell biology
Biology
ATyr Pharma
Neuropilin 2
Single-pass transmembrane proteins
Proteins
Tyrosine kinase receptors
Vascular endothelial growth factor
Neuropilin
VEGF receptor
Breast cancer
aTyr Pharma Inc.

Click the tags to see associated articles and topics

View Article Details
Break Out Ahead? aTyr Pharma Inc (NASDAQ:LIFE) Presents Poster

Added to Collection on: 2021-06-11 11:28:11

Tags for this article:

Medical specialties
Single-pass transmembrane proteins
Branches of biology
Immunology
Medicine
ATyr Pharma
Neuropilin 2
Neuropilin
Immune system
Antibody
Monoclonal antibody
Semaphorin
aTyr Pharma Inc.

Click the tags to see associated articles and topics

View Article Details
D.A. Davidson & CO. Acquires Shares of 10800 aTyr Pharma, Inc. (NASDAQ:LIFE)

Added to Collection on: 2022-10-22 10:18:28

Tags for this article:

Financial markets
Finance
Financial economics
ATyr Pharma
Short
Stock
aTyr Pharma Inc.

Click the tags to see associated articles and topics

View Article Details
Interstitial Lung Disease Pipeline Analysis 2024: FDA Approvals, Clinical Trials, Therapies ...

Added to Collection on: 2024-07-09 11:26:46

Tags for this article:

Lung disorders
ATyr Pharma
Interstitial lung disease
Boehringer Ingelheim
Nintedanib
AstraZeneca
Interstitial
Bristol-Myers Squibb
Lung cancer
Roche
United Therapeutics
Regend Therapeutics
Avalyn Pharmaceuticals
HEC Pharm
Bayer
Interstitial Lung Disease Companies
FibroGen
puretech health
Prometheus Biosciences
Genentech
Avalyn Pharma
Reata Pharmaceuticals
aTyr Pharma Inc.
AdAlta
Taiho Pharmaceutical
CSL Behring
Bristol-Myers Squibb

Click the tags to see associated articles and topics

View Article Details